Latency-Associated Nuclear Antigen 2 (LANA2) 抗体
适用: Human Herpesvirus 8 (HHV-8)
WB, IF, IP, IHC, ELISA
宿主: 小鼠
Monoclonal
CM-A807
unconjugated
1 image
-
- 抗原
- Latency-Associated Nuclear Antigen 2 (LANA2)
- 适用
- Human Herpesvirus 8 (HHV-8)
- 宿主
- 小鼠
- 克隆类型
- 单克隆
- 应用范围
- Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP), Immunohistochemistry (IHC), ELISA
- 特异性
- Reacts with human and murin Kaposi's sarcoma-associated herpes virus (KSHV) ~66-70 kDa LANA2 protein and shows no cross-reactivity to cellular proteins
- 纯化方法
- Purified (protein G)
- 免疫原
- Recombinant LANA2 fusion protein
- 克隆位点
- CM-A807
- 亚型
- IgG1 kappa
-
- 应用备注
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 1/10 to1/2000 - IF : 2 to 4 μg/mL - IP : 2 to 4 μg/mL - WB : 2 to 4 μg/mL - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 2 mg/mL
- 储存条件
- 4 °C/-20 °C
- 储存方法
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- 有效期
- 6 months
-
- 抗原
- Latency-Associated Nuclear Antigen 2 (LANA2)
- 物质类
- Viral Protein
- 背景
- LANA2 (latency-associated nuclear antigen) is an inhibitor of p53-induced transcription in reporter assays and may be an apoptosis antagonist.It is a nuclear protein associated with Kaposi's sarcoma-associated herpes virus (KSHV), or human herpes virus 8.It is found in abundance in the nuclei of cultured cells from KSHV-infected hematopoietic tissues, such as PEL (primary effusion lymphoma) and CD (multicentric Castleman's disease).It does not appear to be expressed in KS (Kaposi's sarcoma) lesions.
-
You are here:
